See also this year's filing and all EDGAR filings for this company.
PDF Report 0001479419_2023_KALA_BIO_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS': 16, '00205 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Calc 2)': 3}} |
Graph
Absolute values for 0001479419, KALA BIO Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 85,942,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 400,000 |
| 3 | remainder_Assets | 478,000 |
| 4 | LiabilitiesCurrent | 25,685,000 |
| 5 | LiabilitiesNoncurrent | 42,161,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 65,035,000 |
| 9 | ResearchAndDevelopmentExpense | 17,653,000 |
| 10 | remainder_Expenses | 2,910,000 |
| 11 | remainder_Revenues | 3,892,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 36,884,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 86,820,000 |
| 1 | Liabilities | 67,846,000 |
| 2 | Expenses | 85,598,000 |
| 3 | Revenues | 3,892,000 |
| 4 | StockholdersEquity | 18,974,000 |
| 5 | NetIncome | -81,706,000 |
| 6 | ComprehensiveNetIncome | -63,264,000 |
| 7 | BaseVar | 140,520,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.283 |
| 9 | EconomicCapitalRatio | 1.40 |
Edgar->Model Mapping
Feature Distribution
